Sangamo Therapeutics
SGMO
#8680
Rank
S$0.22 B
Marketcap
S$0.60
Share price
20.63%
Change (1 day)
-55.34%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: S$0.22 Billion

As of February 2026 Sangamo Therapeutics has a market cap of S$0.22 Billion. This makes Sangamo Therapeutics the world's 8680th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.22 B21.07%
2025S$0.18 B-74.71%
2024S$0.72 B470.55%
2023S$0.12 B-81.55%
2022S$0.68 B-53.3%
2021S$1.47 B-49.42%
2020S$2.91 B123.13%
2019S$1.30 B-18.34%
2018S$1.60 B-13.56%
2017S$1.85 B494.69%
2016S$0.31 B-65.69%
2015S$0.90 B-34.54%
2014S$1.38 B26.71%
2013S$1.09 B180.9%
2012S$0.38 B102.06%
2011S$0.19 B-50.28%
2010S$0.38 B3.79%
2009S$0.37 B83.36%
2008S$0.20 B-73%
2007S$0.75 B112.98%
2006S$0.35 B72.9%
2005S$0.20 B-17.07%
2004S$0.24 B6.66%
2003S$0.23 B79.48%
2002S$0.12 B-69.47%
2001S$0.42 B-43.45%
2000S$0.74 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Sangamo Therapeutics was reported to be:

S$0.20 Billion
by Nasdaq info icon info icon
S$0.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$751.23 B 337,849.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$261.24 B 117,421.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$36.24 B 16,206.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$28.20 B 12,586.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$231.85 B 104,200.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$391.81 B 176,160.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$55.87 B 25,035.72%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$15.22 B 6,750.09%๐Ÿ‡บ๐Ÿ‡ธ USA